Skip to main navigation Skip to search Skip to main content

Correction: Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy, (Biosensors, (2022), 12, (109), 10.3390/bios12020109)

  • Albert Yu
  • , Xiaoyong Dai
  • , Zixian Wang
  • , Huaqing Chen
  • , Bing Guo
  • , Laiqiang Huang*
  • *Corresponding author for this work
  • Tsinghua University
  • Harbin Institute of Technology

Research output: Contribution to journalComment/debate

Abstract

Additional Affiliation(s) In the published publication [1], there was an error regarding the affiliation(s) for Albert Yu, Xiaoyong Dai, ZixianWang, Huaqing Chen, and Laiqiang Huang. In addition to affiliations 1, 2 and 3, the updated affiliations should include: 1. PrecisionMedicine and Healthcare Research Center, Center for Biotechnology and Biomedicine, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, State Key Laboratory of Health Sciences and Technology, Tsinghua-Berkeley Shenzhen Institute (TBSI), Institute of Biopharmaceutical and Health Engineering, Shenzhen InternationalGraduate School, Tsinghua University, Shenzhen 518055, China. 2. School of Science and Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Harbin Institute of Technology, Shenzhen 518055, China. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Original languageEnglish
Article number794
JournalBiosensors
Volume12
Issue number10
DOIs
StatePublished - Oct 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction: Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy, (Biosensors, (2022), 12, (109), 10.3390/bios12020109)'. Together they form a unique fingerprint.

Cite this